Physician profile
Brian Lobo
NPI 1427340454
$30,042.33
in general payments reported to CMS, 2019-2025
9 companies · $15K in 2025
The $15K reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $135 · 2021: $3,087 · 2022: $661 · 2023: $5,110 · 2024: $5,853 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,467 · Food and Beverage: $4,143 · Travel and Lodging: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,119.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,467.00 |
| Food and Beverage | $4,142.76 |
| Travel and Lodging | $1,891.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,026.88 | 2021-2025 | Straightshot, Fusion, Stealthstation S8 Platform |
| 3-D Matrix, INC. | $8,126.11 | 2023-2025 | |
| Genzyme Corporation | $1,845.37 | 2024-2025 | |
| Acclarent, INC | $1,182.43 | 2022-2023 | Trudi Nav Cable, Relieva Spinplus, Acclarent Navwire |
| Stryker Corporation | $832.23 | 2022-2025 | Adherus Autospray Dural Sealant |
| Medtronic USA, INC. | $673.67 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $180.87 | 2023-2024 | Dupixent |
| Integra Lifesciences Corporation | $156.05 | 2024 | Acclarent Aera |
| Astrazeneca Pharmaceuticals Lp | $18.72 | 2023 | Fasenra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lobo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.